25 February 2026
Malaghan ambassador, trustee and living proof of the power of CAR T-cell therapy, David Downs, explores CAR T-cell therapy. He answers some of the common questions Kiwis are asking about this ground-breaking treatment and the Malaghan's efforts to bring it to New Zealand.
Part 1: What is CAR T-cell therapy
Part 2: The Malaghan's ground-breaking trials
Part 3: Breaking ground with clinical trials in New Zealand
Part 4: Why does the Malaghan have to fundraise for CAR-T?
Part 5: Scaling new therapies through commercialisation
Support bringing CAR T-cell therapy to Aotearoa New Zealand
Join us in making CAR T-cell therapy accessible and affordable for all New Zealanders in need.
To learn more about how you can join this ground-breaking effort please contact the Malaghan Institute's philanthropy manager An-Li Theron.
Or, if you're keen to support our efforts in other ways, contact the Malaghan Institute's communications team.
Related articles
Breakthrough Malaghan and University of Auckland cancer research advances into new biotech venture
16 June 2026
HRC funding to improve CAR T-cell ‘fitness’ and better fight cancer
11 June 2026
What's next for CAR T-cell therapy
27 May 2026
Researchers explore 'RENTAL CAR' approach to CAR T-cell therapy
21 May 2026
Ground-breaking CAR-T clinical trial hits midway milestone
15 April 2026
From clinical trial to clinical tool: Bringing CAR-T to patients
26 March 2026